Serum Concentrations of S100B are not Affected by Cycling to Exhaustion With or Without Vibration

被引:11
|
作者
Schulte, Stefanie [1 ]
Schiffer, Thorsten [1 ]
Sperlich, Billy [2 ]
Kleinoeder, Heinz [2 ]
Holmberg, Hans Christer [3 ]
机构
[1] German Sport Univ Cologne, Inst Motor Control & Movement Tech, D-50933 Cologne, Germany
[2] German Sport Univ Cologne, Inst Training Sci & Sport Informat, D-50933 Cologne, Germany
[3] Mid Sweden Univ, Swedish Winter Sports Res Ctr, Dept Hlth Sci, Ostersund, Sweden
关键词
biomarker; neurotrophin; hormone; endurance; serum; NEURON-SPECIFIC ENOLASE; BRAIN-DAMAGE; SEROTONERGIC NEURONS; BIOCHEMICAL MARKERS; CEREBROSPINAL-FLUID; ELITE PLAYERS; S-100B; S100-BETA; INCREASES; PROTEIN;
D O I
10.2478/v10078-011-0073-2
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The calcium-binding protein S100B is produced primarily by astrocytes and exerts concentration-dependent paracrine and autocrine effects on neurons and glia. The numerous findings of a correlation between S100B and traumatic brain injury (TBI) have resulted in the employment of this protein as a clinical biomarker for such injury. Our present aim was to determine whether cycling with (V) or without (NV) vibration alters serum concentrations of S100B. Twelve healthy, male non-smokers (age: 25.3 +/- 1.6 yrs, body mass: 74.2 +/- 5.9 kg, body height: 181.0 +/- 3.7 cm, VO2peak: 56.9 +/- 5.1 ml.min(-1).kg(-1) (means +/- SD)) completed in random order two separate trials to exhaustion on a vibrating bicycle (amplitude 4 mm and frequency 20 Hz) connected to an ergometer. The initial workload of 100 W was elevated by 50 W every 5 min and the mean maximal period of exercise was 25:27 +/- 1:30 min. The S100B in venous blood taken at rest, immediately after the test, and 30, 60 and 240 min post-exercise exhibited no significant differences (p>0.05), suggesting that cycling with and without vibration does not influence this parameter.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 50 条
  • [31] Kinetic modelling of serum S100b after traumatic brain injury
    Ercole, A.
    Thelin, E. P.
    Holst, A.
    Bellander, B. M.
    Nelson, D. W.
    BMC NEUROLOGY, 2016, 16
  • [32] Serum S100B protein after electroconvulsive therapy in patients with depression
    Gbyl, Krzysztof
    Jorgensen, Niklas Rye
    Videbech, Poul
    ACTA NEUROPSYCHIATRICA, 2022, 34 (05): : 269 - 275
  • [33] Detection of S100B in maternal blood before and after fetal death
    Beharier, Ofer
    Shusterman, Eden
    Eshcoli, Tamar
    Szaingurten-Solodkin, Irit
    Aricha-Tamir, Barak
    Weintraub, Adi Y.
    Sheiner, Eyal
    Holcberg, Gershon
    Hershkovitz, Reli
    PRENATAL DIAGNOSIS, 2014, 34 (01) : 94 - 97
  • [34] A new objective method for CT triage after minor head injury - serum S100B
    Unden, Johan
    Romner, Bertil
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2009, 69 (01) : 13 - 17
  • [35] Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events
    Onatsu, Juha
    Vanninen, Ritva
    Jakal, Pekka
    Mustonen, Pirjo
    Pulkki, Kari
    Korhonen, Miika
    Hedman, Marja
    Hoglund, Kina
    Blennow, Kaj
    Zetterberg, Henrik
    Herukka, Sanna-Kaisa
    Taina, Mikko
    IN VIVO, 2020, 34 (05): : 2577 - 2586
  • [36] Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome
    Fujii, Chihiro
    Tokuda, Takahiko
    Ishigami, Noriko
    Mizuno, Toshiki
    Nakagawa, Masanori
    NEUROSCIENCE LETTERS, 2011, 494 (01) : 86 - 88
  • [37] A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children
    Al-Ayadhi, Laila Yousef
    Mostafa, Gehan Ahmed
    JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [38] Serum S100B and intelligence in children with Down syndrome
    Noviarisa, Nurul
    Chundrayetti, Eva
    Lubis, Gustina
    PAEDIATRICA INDONESIANA, 2019, 59 (03) : 125 - 129
  • [39] Evaluating S100B as a serum biomarker for central neurosarcoidosis
    Moss, B. P.
    Patel, D. C.
    Tavee, J. O.
    Culver, D. A.
    RESPIRATORY MEDICINE, 2020, 162
  • [40] Increased S100B Levels in Cannabis Use Disorder
    Bayazit, Huseyin
    Cicek, Erdinc
    Selek, Salih
    Aksoy, Nurten
    Karababa, I. Fatih
    Kandemir, Hasan
    Kandemir, Sultan Basmaci
    EUROPEAN ADDICTION RESEARCH, 2016, 22 (04) : 177 - 180